Advanced searches left 3/3

EPOGEN - DOAJ

Summarized by Plex Scholar
Last Updated: 09 April 2022

* If you want to update the article please login/register

Treatment of confirmed B12 deficiency in hemodialysis patients improves Epogen® requirements

Background: Vitamin B12 deficiency can have deleterious effects on end stage renal disease patients on maintenance hemodialysis, Mark Samarneh, Norbert Shtaynberg, Rabih Nasr, Elie El-Charabaty, Suzanne El-Charabaty, Staten Island University Hospital, Staten Island, NY, USA Background: Despite that little is known about its prevalence in this group, yet no data is available. All patients with B12 deficiency were tested for peripheral smears. B12 deficiency was present at 58% as a result of a positive MMA level and a positive blood smear. The mean monthly EPO dose was 82,067; 47,906 and pub; 39,691. Conclusion: Vitamin B12 supplementation has been attributed to a decrease in the average dose of ESA therapy while maintaining a stable hemoglobin level.

Source link: https://doaj.org/article/48fef5274e29456883dd283aa838f127

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions